Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kimi Kondo

Concepts (161)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiology
4
2017
175
0.600
Why?
Lymphocele
1
2013
2
0.390
Why?
Surgery, Computer-Assisted
1
2013
87
0.360
Why?
Curriculum
4
2018
1079
0.340
Why?
Faculty
1
2013
152
0.340
Why?
Kidney Neoplasms
4
2016
419
0.260
Why?
Kidney Failure, Chronic
1
2013
589
0.250
Why?
Kidney Transplantation
1
2013
735
0.240
Why?
Clinical Competence
1
2013
1272
0.210
Why?
Portasystemic Shunt, Transjugular Intrahepatic
2
2016
37
0.210
Why?
Attitude of Health Personnel
1
2013
1219
0.210
Why?
Angiomyolipoma
2
2016
21
0.210
Why?
Ultrasonography, Interventional
2
2016
163
0.200
Why?
Diagnostic Imaging
2
2016
340
0.180
Why?
Internship and Residency
1
2013
1281
0.180
Why?
Students, Medical
2
2017
383
0.160
Why?
Education, Medical, Undergraduate
2
2018
208
0.140
Why?
Radiology, Interventional
1
2018
49
0.130
Why?
Schools, Medical
2
2018
158
0.120
Why?
Vena Cava Filters
1
2017
68
0.120
Why?
Pregnancy, Abdominal
1
2016
2
0.120
Why?
Thromboembolism
1
2017
129
0.120
Why?
Radiology Information Systems
1
2016
35
0.120
Why?
Biotechnology
1
2016
45
0.120
Why?
Laboratories
1
2017
109
0.120
Why?
Tuberous Sclerosis
1
2016
56
0.120
Why?
Teaching
1
2018
244
0.110
Why?
Organizational Innovation
1
2016
124
0.110
Why?
Hypertension, Portal
1
2016
66
0.110
Why?
Cavernous Sinus
1
2015
16
0.110
Why?
Venous Insufficiency
1
2015
12
0.110
Why?
Prosthesis Design
1
2017
358
0.110
Why?
Venous Thrombosis
1
2017
199
0.110
Why?
Methotrexate
1
2016
234
0.110
Why?
Pulmonary Embolism
1
2017
246
0.110
Why?
Arteriovenous Fistula
1
2015
36
0.110
Why?
Intracranial Arteriovenous Malformations
1
2015
53
0.110
Why?
Personal Satisfaction
1
2017
218
0.110
Why?
Radiography, Interventional
1
2016
128
0.110
Why?
Portal Vein
1
2016
123
0.100
Why?
Radiology Department, Hospital
1
2014
16
0.100
Why?
Hernia, Abdominal
1
2013
7
0.100
Why?
Ascites
1
2013
48
0.100
Why?
Education, Medical, Graduate
1
2018
568
0.100
Why?
Hernia, Inguinal
1
2013
47
0.100
Why?
Intestinal Obstruction
1
2013
54
0.090
Why?
Embolization, Therapeutic
1
2015
246
0.090
Why?
Chemoembolization, Therapeutic
1
2013
88
0.090
Why?
Cholangiocarcinoma
1
2013
110
0.090
Why?
Translocation, Genetic
1
2012
127
0.080
Why?
Education, Medical
1
2014
274
0.080
Why?
Radiography
1
2013
861
0.080
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2011
128
0.080
Why?
Treatment Outcome
6
2016
11821
0.080
Why?
Receptor Protein-Tyrosine Kinases
1
2012
227
0.080
Why?
Disease Progression
3
2013
2867
0.070
Why?
Neoplasms, Multiple Primary
1
2010
57
0.070
Why?
Delivery of Health Care
1
2016
947
0.070
Why?
Carcinoma, Papillary
1
2009
83
0.070
Why?
Drug Resistance, Neoplasm
2
2012
893
0.070
Why?
Piperazines
1
2011
368
0.070
Why?
Neuroblastoma
1
2010
177
0.070
Why?
Pyrazoles
1
2012
517
0.070
Why?
Pyrimidines
1
2011
532
0.060
Why?
Pyridines
1
2012
610
0.060
Why?
Lung Neoplasms
2
2012
2675
0.060
Why?
Liver Neoplasms
1
2013
776
0.060
Why?
Urinary Bladder Neoplasms
1
2009
259
0.060
Why?
DNA Methylation
1
2011
725
0.060
Why?
Anatomic Landmarks
2
2016
31
0.060
Why?
Protein Kinase Inhibitors
1
2012
983
0.060
Why?
United States
4
2018
16136
0.050
Why?
Surveys and Questionnaires
2
2018
6073
0.050
Why?
Aged
5
2016
26432
0.050
Why?
Carcinoma, Non-Small-Cell Lung
1
2012
1195
0.050
Why?
Humans
15
2018
146342
0.050
Why?
Tomography, X-Ray Computed
4
2016
2786
0.040
Why?
Incidence
2
2016
2936
0.030
Why?
Young Adult
4
2016
14330
0.030
Why?
Male
6
2016
73396
0.030
Why?
Intergenerational Relations
1
2017
20
0.030
Why?
Forecasting
1
2018
388
0.030
Why?
Inventions
1
2016
18
0.030
Why?
Hemoperitoneum
1
2016
10
0.030
Why?
Neoplasm Staging
2
2011
1488
0.030
Why?
Portography
1
2016
7
0.030
Why?
Portal Pressure
1
2016
4
0.030
Why?
Career Choice
1
2018
237
0.030
Why?
History, 20th Century
1
2017
330
0.030
Why?
Device Removal
1
2017
149
0.030
Why?
Pregnancy, Ectopic
1
2016
54
0.030
Why?
Injections, Intramuscular
1
2016
140
0.030
Why?
Models, Organizational
1
2016
145
0.030
Why?
Delayed Diagnosis
1
2016
102
0.030
Why?
Female
8
2016
79499
0.030
Why?
Radiation Exposure
1
2016
62
0.030
Why?
Fluoroscopy
1
2016
179
0.030
Why?
Operative Time
1
2016
195
0.030
Why?
Abdominal Pain
1
2016
149
0.030
Why?
Program Development
1
2017
371
0.030
Why?
Radiation Dosage
1
2016
193
0.030
Why?
Carbon Dioxide
1
2016
228
0.030
Why?
Spleen
1
2016
503
0.030
Why?
Liver Cirrhosis
1
2016
278
0.020
Why?
Time Factors
2
2016
7109
0.020
Why?
Bile Ducts, Intrahepatic
1
2013
62
0.020
Why?
Adult
5
2016
41087
0.020
Why?
Retrospective Studies
3
2016
17438
0.020
Why?
Contrast Media
1
2016
493
0.020
Why?
Program Evaluation
1
2017
952
0.020
Why?
Chi-Square Distribution
1
2013
517
0.020
Why?
Ultrasonography
1
2016
788
0.020
Why?
Bile Duct Neoplasms
1
2013
132
0.020
Why?
Genes, Neoplasm
1
2011
26
0.020
Why?
Laparoscopy
1
2016
487
0.020
Why?
Genotype
1
2016
1879
0.020
Why?
Imatinib Mesylate
1
2011
77
0.020
Why?
Gene Expression Regulation, Leukemic
1
2011
57
0.020
Why?
Data Collection
1
2014
650
0.020
Why?
Adolescent
3
2016
22557
0.020
Why?
ras Proteins
1
2012
148
0.020
Why?
DNA Copy Number Variations
1
2012
192
0.020
Why?
Proto-Oncogene Proteins p21(ras)
1
2012
250
0.020
Why?
Kaplan-Meier Estimate
1
2013
970
0.020
Why?
Reoperation
1
2013
645
0.020
Why?
Benzamides
1
2011
226
0.020
Why?
Middle Aged
4
2016
36619
0.020
Why?
Sensitivity and Specificity
1
2015
1998
0.020
Why?
Oncogene Proteins, Fusion
1
2012
213
0.020
Why?
Protein Structure, Tertiary
1
2012
834
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2011
752
0.020
Why?
Risk Factors
2
2013
10921
0.020
Why?
Genome, Human
1
2011
431
0.020
Why?
Neoplasm Metastasis
1
2011
693
0.020
Why?
Nephrectomy
1
2010
172
0.020
Why?
Kidney
1
2016
1498
0.020
Why?
Sequence Analysis, DNA
1
2011
771
0.020
Why?
Proto-Oncogene Proteins
1
2012
616
0.020
Why?
ErbB Receptors
1
2012
636
0.020
Why?
Algorithms
1
2016
1849
0.020
Why?
Survival Analysis
1
2011
1378
0.020
Why?
Positron-Emission Tomography
1
2009
343
0.020
Why?
Cisplatin
1
2009
347
0.020
Why?
Multivariate Analysis
1
2011
1543
0.020
Why?
Reproducibility of Results
1
2015
3416
0.020
Why?
Models, Molecular
1
2012
1574
0.020
Why?
Cell Line
1
2012
2814
0.010
Why?
Infant, Newborn
1
2016
6460
0.010
Why?
Colorado
1
2013
4595
0.010
Why?
Cell Line, Tumor
1
2011
3545
0.010
Why?
Pregnancy
1
2016
7230
0.010
Why?
Neoplasm Recurrence, Local
1
2009
1160
0.010
Why?
Aged, 80 and over
1
2015
8391
0.010
Why?
Infant
1
2016
10114
0.010
Why?
Child, Preschool
1
2016
11913
0.010
Why?
Prognosis
1
2010
4351
0.010
Why?
Mutation
1
2012
4093
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1998
0.010
Why?
Antineoplastic Agents
1
2009
2219
0.010
Why?
Magnetic Resonance Imaging
1
2010
3926
0.010
Why?
Child
1
2016
22693
0.010
Why?
Kondo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)